Modus Therapeutics Holding AB (OSTO:MODTX) Tariff Resilience Score: 0/10 (As of Jul. 09, 2026)


OSTO:MODTX Modus Therapeutics Holding AB OSTO:MODTX
25 GF Score
Price kr0.37
! 1 Warning Sign
View Full Analysis

What is Modus Therapeutics Holding AB Tariff Resilience Score?

Modus Therapeutics Holding AB has the Tariff Resilience Score of 0, which implies that the company might have .

Modus Therapeutics Holding AB has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Modus Therapeutics Holding AB might have .

Modus Therapeutics Holding AB  (OSTO:MODTX) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Modus Therapeutics Holding AB Tariff Resilience Score Related Terms

OSTO:MODTX
25GF Score
Modus Therapeutics Holding AB OSTO:MODTX
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Modus Therapeutics Holding AB Business Description

Address Olof Palmes gata 29 IV, Stockholm, SWE, 111 22
Modus Therapeutics Holding AB is a Swedish biotechnology company developing its patented polysaccharide, sevuparin, as a potential treatment for unmet medical needs. Its research focuses on conditions involving severe systemic inflammation, including sepsis and septic shock, severe malaria, and other related disorders, as well as anemia associated with chronic inflammatory conditions such as kidney disease.
25GF Score

Get the complete analysis for OSTO:MODTX

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.37
Price